search
Back to results

Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY

Primary Purpose

Taste Disorder, Primary, Sweet

Status
Completed
Phase
Phase 1
Locations
Switzerland
Study Type
Interventional
Intervention
lactisole
mixed liquid meal
Sponsored by
University Hospital, Basel, Switzerland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Taste Disorder, Primary, Sweet focused on measuring T1R2/T1R3, gastric emptying, gut, lactisole, nutrient sensing

Eligibility Criteria

18 Years - 40 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy subjects
  • BMI of 19.0-24.5
  • Age 18-40
  • stable body weight for at least 3 month

Exclusion Criteria:

  • smoking
  • substance abuse
  • regular intake of medication
  • medical or psychiatric illness
  • gastrointestinal disorders or food allergies

Sites / Locations

  • University Hospital Basel, Phase 1 Research Unit

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

glucose

glucose + lactisole

mixed liquid meal

mixed liquid meal + lactisole

saline + lactisole

Arm Description

intraduodenal perfusion of glucose (29.3 g glucose per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min)

intraduodenal perfusion of glucose (29.3 g glucose per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min) + 450 ppm lactisole

intraduodenal perfusion of a mixed liquid meal (20.20 g carbohydrate, 4.92 g fat and 6.25 g protein per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min)

intraduodenal perfusion of a mixed liquid meal (20.20 g carbohydrate, 4.92 g fat and 6.25 g protein per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min) + 450 ppm lactisole

saline (0.9 %; rate: 2.5 mL/min for 180 min) + 450 ppm lactisole

Outcomes

Primary Outcome Measures

Gastrointestinal peptide secretion
Assessment of venous GLP-1 and PYY release to meal stimulation with and without sweet receptor blockade

Secondary Outcome Measures

Appetite perceptions during 4 hours using VAS
Assessment of the following appetite perception markers: feelings of hunger, feelings of fullness, feelings of satiety using validated visual analogue scales

Full Information

First Posted
February 22, 2011
Last Updated
July 15, 2015
Sponsor
University Hospital, Basel, Switzerland
search

1. Study Identification

Unique Protocol Identification Number
NCT01304823
Brief Title
Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY
Official Title
The Role of Sweet Taste Receptor Blockade on Intraduodenal Glucose- and Liquid Meal-stimulated Secretion of Satiation Peptides in Healthy Humans
Study Type
Interventional

2. Study Status

Record Verification Date
July 2015
Overall Recruitment Status
Completed
Study Start Date
June 2010 (undefined)
Primary Completion Date
August 2010 (Actual)
Study Completion Date
January 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Basel, Switzerland

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the functional significance of sweet taste receptors in the secretion of GI satiation peptides by using a specific sweet taste receptor antagonist to block sweet taste perception in the gastrointestinal tract.
Detailed Description
There is strong evidence that taste signaling mechanisms identified in the oral epithelium also operate in the gut. It is suggested that open-type enteroendocrine cells directly sense nutrient via alpha-gustducin coupled taste receptors to modulate the secretion of glucagon like peptide-1 (GLP-1) and peptide YY (PYY). Several nutrient responsive G-protein coupled receptors have been identified in the human gut, including the sweet taste responsive T1R2/T1R3 heterodimer, the amino acid/umami responsive T1R1/T1R3 as well as GPR120 for unsaturated long-chain free fatty acids.The functional significance of sweet taste receptors in the secretion of GLP-1 and PYY will be determined by intraduodenal perfusion of glucose (I) or a mixed liquid meal (II) with or without lactisole (450 ppm) in a double blind, 5-way crossover trial including 10 healthy subjects.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Taste Disorder, Primary, Sweet
Keywords
T1R2/T1R3, gastric emptying, gut, lactisole, nutrient sensing

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 1
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
glucose
Arm Type
Active Comparator
Arm Description
intraduodenal perfusion of glucose (29.3 g glucose per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min)
Arm Title
glucose + lactisole
Arm Type
Active Comparator
Arm Description
intraduodenal perfusion of glucose (29.3 g glucose per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min) + 450 ppm lactisole
Arm Title
mixed liquid meal
Arm Type
Active Comparator
Arm Description
intraduodenal perfusion of a mixed liquid meal (20.20 g carbohydrate, 4.92 g fat and 6.25 g protein per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min)
Arm Title
mixed liquid meal + lactisole
Arm Type
Active Comparator
Arm Description
intraduodenal perfusion of a mixed liquid meal (20.20 g carbohydrate, 4.92 g fat and 6.25 g protein per 100 mL; rate: 2.5 mL/min for 180 min; caloric load: 3.0 kcal/min) + 450 ppm lactisole
Arm Title
saline + lactisole
Arm Type
Placebo Comparator
Arm Description
saline (0.9 %; rate: 2.5 mL/min for 180 min) + 450 ppm lactisole
Intervention Type
Dietary Supplement
Intervention Name(s)
lactisole
Other Intervention Name(s)
Dietary supplement
Intervention Description
flavoring agent/sweet taste antagonist
Intervention Type
Other
Intervention Name(s)
mixed liquid meal
Other Intervention Name(s)
Dietary supplement
Intervention Description
Ensure Plus
Primary Outcome Measure Information:
Title
Gastrointestinal peptide secretion
Description
Assessment of venous GLP-1 and PYY release to meal stimulation with and without sweet receptor blockade
Time Frame
4 hours blood sampling
Secondary Outcome Measure Information:
Title
Appetite perceptions during 4 hours using VAS
Description
Assessment of the following appetite perception markers: feelings of hunger, feelings of fullness, feelings of satiety using validated visual analogue scales
Time Frame
4 hours

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy subjects BMI of 19.0-24.5 Age 18-40 stable body weight for at least 3 month Exclusion Criteria: smoking substance abuse regular intake of medication medical or psychiatric illness gastrointestinal disorders or food allergies
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christoph Beglinger, MD
Organizational Affiliation
Phase 1 Research Unit, University Hospital Basel
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Basel, Phase 1 Research Unit
City
Basel
ZIP/Postal Code
4031
Country
Switzerland

12. IPD Sharing Statement

Citations:
PubMed Identifier
22215654
Citation
Steinert RE, Meyer-Gerspach AC, Beglinger C. The role of the stomach in the control of appetite and the secretion of satiation peptides. Am J Physiol Endocrinol Metab. 2012 Mar 15;302(6):E666-73. doi: 10.1152/ajpendo.00457.2011. Epub 2012 Jan 3.
Results Reference
result
PubMed Identifier
21324568
Citation
Steinert RE, Gerspach AC, Gutmann H, Asarian L, Drewe J, Beglinger C. The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr. 2011 Aug;30(4):524-32. doi: 10.1016/j.clnu.2011.01.007. Epub 2011 Feb 15.
Results Reference
result

Learn more about this trial

Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY

We'll reach out to this number within 24 hrs